Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review.

MLA

Buczyńska, Angelika, et al. “Exploring the Clinical Utility of DPP-IV and SGLT2 Inhibitors in Papillary Thyroid Cancer: A Literature Review.” Frontiers in Pharmacology, vol. 15, Jan. 2024, p. 1323083. EBSCOhost, https://doi.org/10.3389/fphar.2024.1323083.

APA

Buczyńska, A., Kościuszko, M., Krętowski, A. J., & Popławska-Kita, A. (2024). Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review. Frontiers in Pharmacology, 15, 1323083. https://doi.org/10.3389/fphar.2024.1323083

Chicago

Buczyńska, Angelika, Maria Kościuszko, Adam Jacek Krętowski, and Anna Popławska-Kita. 2024. “Exploring the Clinical Utility of DPP-IV and SGLT2 Inhibitors in Papillary Thyroid Cancer: A Literature Review.” Frontiers in Pharmacology 15 (January): 1323083. doi:10.3389/fphar.2024.1323083.